Medical therapy in acromegaly.

Research output: Contribution to journalArticle

Standard

Medical therapy in acromegaly. / Sherlock, Mark; Woods, C; Sheppard, Michael.

In: Nature Reviews Endocrinology, Vol. 7, No. 5, 01.05.2011, p. 291-300.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{9276be1b74bd4da08aec24a2c059332d,
title = "Medical therapy in acromegaly.",
abstract = "Acromegaly is a rare disease characterized by excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. The disease is associated with increased morbidity and premature mortality, but these effects can be reduced if GH levels are decreased to ",
author = "Mark Sherlock and C Woods and Michael Sheppard",
year = "2011",
month = may,
day = "1",
doi = "10.1038/nrendo.2011.42",
language = "English",
volume = "7",
pages = "291--300",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Medical therapy in acromegaly.

AU - Sherlock, Mark

AU - Woods, C

AU - Sheppard, Michael

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Acromegaly is a rare disease characterized by excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. The disease is associated with increased morbidity and premature mortality, but these effects can be reduced if GH levels are decreased to

AB - Acromegaly is a rare disease characterized by excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. The disease is associated with increased morbidity and premature mortality, but these effects can be reduced if GH levels are decreased to

U2 - 10.1038/nrendo.2011.42

DO - 10.1038/nrendo.2011.42

M3 - Article

C2 - 21448141

VL - 7

SP - 291

EP - 300

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 5

ER -